Description
HGH 176–191
HGH Fragment 176–191 is a modified peptide (a portion of the human growth hormone) primarily researched for promoting significant fat loss, accelerating metabolic rates, and enhancing energy levels without the growth-inducing side effects of full-length HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis, specifically targeting stubborn fat areas.
-
Targeted Fat Reduction:
It is specialized to stimulate lipolysis (the breakdown of fat) and inhibit lipogenesis (the formation of new fat), often used for treating obesity. -
No Growth Effects:
Unlike full-chain HGH, fragment 176-191 does not raise insulin levels, cause hyperglycemia, or cause unwanted tissue growth. -
Improved Metabolism:
It supports a higher metabolic rate, helping to burn calories faster. -
Muscle Preservation:
While focusing on fat loss, studies suggest it helps maintain lean muscle mass. -
Potential Anti-Cancer Research:
Studies suggest it can enhance the toxicity of certain agents against breast cancer cells, potentially improving therapeutic efficacy. -
Recovery and Wellness:
Some user reports indicate improved recovery times, though this is less documented in formal clinical trials.


